1.35
price down icon4.26%   -0.06
after-market Handel nachbörslich: 1.35
loading

Finanzdaten der Pliant Therapeutics Inc-Aktie (PLRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
38.00%
28.27
45.59 58.94 62.01 60.64
Operating Income/Loss
38.00%
-28.27
-45.59 -58.94 -62.01 -60.64
Income/Loss From Continuing Operations Before Tax
39.26%
-26.30
-43.30 -56.17 -57.76 -55.85
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
39.26%
-26.30
-43.30 -56.17 -57.76 -55.85
Net Income/Loss
39.26%
-26.30
-43.30 -56.17 -57.76 -55.85
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.03%
61.41
61.39 61.22 60.73 60.38
Diluted Average Shares
0.03%
61.41
61.39 61.22 60.73 60.38
Basic Earnings Per Share
39.44%
-0.43
-0.71 -0.92 -0.95 -0.92
Diluted Earnings Per Share
39.44%
-0.43
-0.71 -0.92 -0.95 -0.92
Common Stock Dividends
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):